Cassava Sciences Inc (SAVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,628 | -5,957 | -2,583 | -12,386 | -10,230 |
| Depreciation Amortization | 32 | 18 | 4 | 15 | 10 |
| Accounts payable and accrued liabilities | 725 | 292 | 82 | -272 | 377 |
| Other Working Capital | 1,455 | 1,002 | 470 | -937 | 477 |
| Other Operating Activity | 1,911 | 1,550 | 880 | 4,031 | 2,380 |
| Operating Cash Flow | $-5,505 | $-3,095 | $-1,147 | $-9,549 | $-6,986 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -897 | -948 | -1,999 | 1,252 | 150 |
| PPE Investments | -195 | -195 | -195 | -80 | -79 |
| Investing Cash Flow | $-1,092 | $-1,143 | $-2,194 | $1,172 | $71 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 379 | 379 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $379 | $379 |
| Beginning Cash Position | 40,590 | 40,590 | 40,590 | 48,588 | 48,588 |
| End Cash Position | 33,993 | 36,352 | 37,249 | 40,590 | 42,052 |
| Net Cash Flow | $-6,597 | $-4,238 | $-3,341 | $-7,998 | $-6,536 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,505 | -3,095 | -1,147 | -9,549 | -6,986 |
| Capital Expenditure | -195 | -195 | -195 | -80 | -79 |
| Free Cash Flow | -5,700 | -3,290 | -1,342 | -9,629 | -7,065 |